Botulinum Toxin for the Treatment of Motor and Phonic Tics: A Case Report.
[OBJECTIVE] To present a unique approach to the treatment of motor and phonic tics.
APA
Kohli N, Blitzer A (2020). Botulinum Toxin for the Treatment of Motor and Phonic Tics: A Case Report.. The Annals of otology, rhinology, and laryngology, 129(6), 625-627. https://doi.org/10.1177/0003489419898211
MLA
Kohli N, et al.. "Botulinum Toxin for the Treatment of Motor and Phonic Tics: A Case Report.." The Annals of otology, rhinology, and laryngology, vol. 129, no. 6, 2020, pp. 625-627.
PMID
31906695
Abstract
[OBJECTIVE] To present a unique approach to the treatment of motor and phonic tics.
[PATIENT] A 26-year-old male presented with motor and phonic tics including grunting, coughing, and throat clearing.
[INTERVENTION] The patient was treated with 2.5 units of onabotulinum toxin A (BoNT) to the facial mimetic musculature and 2.5 units to each supraglottic musculature via a transthyrohyoid membrane approach under fiberoptic visualization.
[RESULTS] The patient experienced reduction in the frequency, intensity, and interference with daily life of motor and phonic tics on the Yale Global Tic Severity Scale (YGTSS).
[CONCLUSION] This patient experienced subjective and objective decreases in tic severity using a unique approach in the treatment of phonic tics. Results suggest a novel approach in the treatment of phonic tics and bolster the data regarding safe and effective use of BoNT for tic disorder.
[LEVEL OF EVIDENCE] Level V, case report.
[PATIENT] A 26-year-old male presented with motor and phonic tics including grunting, coughing, and throat clearing.
[INTERVENTION] The patient was treated with 2.5 units of onabotulinum toxin A (BoNT) to the facial mimetic musculature and 2.5 units to each supraglottic musculature via a transthyrohyoid membrane approach under fiberoptic visualization.
[RESULTS] The patient experienced reduction in the frequency, intensity, and interference with daily life of motor and phonic tics on the Yale Global Tic Severity Scale (YGTSS).
[CONCLUSION] This patient experienced subjective and objective decreases in tic severity using a unique approach in the treatment of phonic tics. Results suggest a novel approach in the treatment of phonic tics and bolster the data regarding safe and effective use of BoNT for tic disorder.
[LEVEL OF EVIDENCE] Level V, case report.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 |
MeSH Terms
Adult; Botulinum Toxins, Type A; Facial Muscles; Humans; Injections, Intramuscular; Laryngeal Muscles; Male; Neuromuscular Agents; Tourette Syndrome; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (1)
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.